Fundraising FoxGliocart
1 known investors
Find your way into Gliocart
Sign up to see every warm intro you have to Gliocart
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Gliocart team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GlioCART develops a dual-action CAR-T cell therapy for glioblastoma that targets tumor cells while reprogramming tumor-supporting myeloid cells into active immune effectors. The company aims to extend CAR-T therapy to solid tumors and other myeloid-driven cancers.
Investors · 1
Frequently asked questions
- What does Gliocart do?
- GlioCART develops a dual-action CAR-T cell therapy for glioblastoma that targets tumor cells while reprogramming tumor-supporting myeloid cells into active immune effectors. The company aims to extend CAR-T therapy to solid tumors and other myeloid-driven cancers.
- Who are Gliocart's investors?
- Gliocart's investors include Kickfund.